Chorus Ltd (CNU.AX) stock: key figures, P/E, revenue and dividend
Communication Services · Alternative Carriers · Australia · ISIN NZCNUE0001S2
Chorus Ltd financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 950.00 m NZD | 1.03 bn NZD |
| Gross profit | 950.00 m NZD | 385.70 m NZD |
| Operating income | 180.00 m NZD | 286.78 m NZD |
| EBIT | 233.00 m NZD | 286.78 m NZD |
| Net income | 4.00 m NZD | 36.97 m NZD |
| Diluted EPS – continuing operations | 0.01 NZD | 0.07 NZD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Chorus Ltd
Chorus Limited, together with its subsidiaries, engages in the provision of fixed line communications infrastructure services in New Zealand. The company offers wholesale broadband, data, and voice services. It also provides a network of fiber and copper cables, ducts, poles, network electronics, and IT systems. In addition, the company offers value-added network services; physical storage and site-sharing rental services for co-location of third party or shared asset; and installation, wiring, and consultation services. Chorus Limited was incorporated in 2011 and is based in Wellington, New Zealand.
More stocks
- Eastern Communications Co Ltd A (600776.SS)
- BLACKLINE, INC. (BL)
- BioMar Group A/S (BIOMAR.CO)
- Beijing Jetsen Tech Co (300182.SZ)
- HBX Group International PLC (HBX.MC)
- Shenzhen Microgate Technology Co Ltd (300319.SZ)
- Xinhuanet Co Ltd (603888.SS)
- GORMAN RUPP CO (GRC)
- SMA Solar Technology (S92.DE)
- LEMAITRE VASCULAR INC (LMAT)
- Grand Pharmaceutical Group Ltd (512.HK)
- Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707.SS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.